Turtle Creek Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$708K Buy
1,831
+1,024
+127% +$380K 0.04% 214
2026
Q1
$236K Sell
807
-111
-12% -$36.5K 0.02% 370
2025
Q4
$322K Buy
918
+60
+7% +$20.3K 0.03% 288
2025
Q3
$277K Buy
+858
New +$267K 0.02% 293
2024
Q1
Sell
-119
Closed -$56.1K 385
2023
Q4
$56.1K Buy
+119
New +$55K 0.02% 257

Other funds holding ELV

Turtle Creek Wealth Advisors's ELV Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Elevance Health (ELV) stake by 127% in Q2 2026, buying an estimated $380K and bringing the position to 1,831 shares worth $708K. The position accounts for 0.04% of the portfolio, ranked #214.

Turtle Creek Wealth Advisors first reported a position in ELV in Q4 2023 and has held it in 5 quarters since. 700 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Turtle Creek Wealth Advisors held 1,831 shares of Elevance Health worth $708K as of Q2 2026.
  • Turtle Creek Wealth Advisors bought 1,024 Elevance Health shares in Q2 2026, an estimated $380K.
  • Elevance Health made up 0.04% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #214 holding.
  • Turtle Creek Wealth Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 5 quarters since.
  • 700 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.